With more than 10 years of experience in pediatric hematology and oncology, this physician specializes in the diagnosis and treatment of childhood blood disorders and cancers, with particular expertise in pediatric sarcoma, pediatric solid tumors, osteosarcoma, synovial sarcoma, and other bone and soft tissue malignancies. His clinical expertise includes the evaluation and management of refractory, recurrent, and metastatic pediatric cancers, multidisciplinary treatment planning, pediatric oncology care, and hematologic disorders affecting children.

His professional experience includes serving as a Pediatric Hematologist-Oncologist, Director of a Pediatric Sarcoma Program, and Associate Professor within the public and academic healthcare sectors. His work has focused on the diagnosis, treatment, and clinical management of pediatric hematologic disorders and childhood cancers, with an emphasis on osteosarcoma, rhabdomyosarcoma, Ewing sarcoma, synovial sarcoma, and other pediatric solid tumors. In addition to his clinical responsibilities, he has led and participated in translational research, clinical trials, and multidisciplinary treatment initiatives involving targeted therapies, molecular diagnostics, cancer imaging, and novel therapeutic approaches for pediatric sarcoma and other childhood malignancies. He has also authored numerous peer-reviewed publications and scientific presentations addressing pediatric oncology, sarcoma treatment, and childhood cancer research.

He earned a Doctor of Medicine degree and completed postgraduate training in Pediatrics, followed by fellowship training in Pediatric Hematology and Oncology. He is board certified in Pediatrics and Pediatric Hematology-Oncology. His professional affiliations include the American Society of Clinical Oncology (ASCO), the American Society of Pediatric Hematology/Oncology (ASPHO), the Connective Tissue Oncology Society (CTOS), the Children's Oncology Group (COG), the Sarcoma Alliance for Research Through Collaboration (SARC), the International Ewing Sarcoma Research Forum, and the Society for Pediatric Research (SPR). In addition to his clinical and research activities, he serves on editorial boards and as a peer reviewer for numerous oncology and pediatric hematology journals, reflecting his continued contributions to pediatric cancer research and clinical practice.